SARS-CoV-2 2019-nCoV And Influenza A And B Virus Combined Nucleic Acid Detection Kit (Fluorescence P

CLIA-waived PCR detection kit for simultaneous identification of SARS-CoV-2 and Influenza A/B using direct fluorescence technology. Enables rapid respiratory pathogen screening in clinical and point-of-care settings with streamlined sample-to-result workflow.

Fluorescence PCR-based detection kit for rapid identification of Influenza A and B viruses in clinical specimens. Designed for molecular diagnostics in laboratory settings with high sensitivity and specificity for influenza virus screening and confirmation.

CLIA-waived fluorescence PCR detection kit for rapid SARS-CoV-2 identification. The AccuFluor platform delivers real-time PCR results for COVID-19 diagnosis with 510(k) clearance, enabling healthcare facilities to quickly screen patients and guide clinical management decisions.

A PCR-fluorescence diagnostic kit for simultaneous detection of SARS-CoV-2, Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus. The kit provides 6-plex detection with internal control and is designed for use with the Galaxy Nano system.

This diagnostic kit detects SARS-CoV-2 (COVID-19), Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus using PCR-fluorescence technology. Influenza A viruses are most likely to cause epidemic outbreaks due to proneness to genetic mutations, increasing infectivity and pathogenicity, often causing worldwide periodic epidemics. Influenza B viruses often cause local outbreaks. Respiratory syncytial virus is the most common and important pathogen of lower respiratory tract infections in infants and young children, easily causing bronchiolitis and pneumonia with serious complications.

A fluorescence PCR-based nucleic acid detection kit for detection of Novel Coronavirus (2019-nCoV). Used as a diagnostic test for COVID-19 detection.

CE-marked rapid self-test kit for simultaneous detection of SARS-CoV-2, Influenza A+B, and RSV with 92.9%+ sensitivity. Delivers point-of-care respiratory diagnostics using fluorescence immunoassay technology for clinical and home-based testing environments.

A PCR-fluorescence diagnostic kit for simultaneous detection of Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus. The kit provides 4-plex detection with internal control and is designed for use with the Galaxy Nano system.

A multiplex diagnostic test kit for nucleic acid detection of SARS-CoV-2, influenza A, and influenza B. This kit enables molecular diagnosis of multiple respiratory pathogens in clinical samples.

Rapid molecular detection kit for simultaneous identification of SARS-CoV-2, influenza A, and influenza B viruses. Utilizes isothermal amplification technology for quick diagnostic results.

Multiplex PCR test kit for simultaneous detection of COVID-19, Influenza A, and Influenza B nucleic acids. Designed for rapid respiratory pathogen identification in clinical and laboratory settings. Delivers high sensitivity and specificity for differential diagnosis of acute respiratory infections.

A rapid antigen test kit for simultaneous detection of Influenza A, Influenza B, and COVID-19 (SARS-CoV-2). This combo test enables efficient screening for multiple respiratory viruses in a single procedure.